Staphylococcus aureus Bacteremia, Australia

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Collignon, Peter ; Nimmo, Graeme R. ; Gottlieb, Thomas ; Gosbell, Iain B.
• Corporate Authors:
  on behalf of the Australian Group on Antimicrobial Resistance
• Description:
  Staphylococcus aureus bacteremia (SAB) is common and increasing worldwide. A retrospective review was undertaken to quantify the number of cases, their place of acquisition, and the proportions caused by methicillin-resistant S. aureus (MRSA) in 17 hospitals in Australia. Of 3,192 episodes, 1,571 (49%) were community onset. MRSA caused 40% of hospital-onset episodes and 12% of community-onset episodes. The median rate of SAB was 1.48/1,000 admissions (range 0.61-3.24; median rate for hospital-onset SAB was 0.7/1,000 and for community onset 0.8/1,000 admissions). Using these rates, we estimate that approximately 6,900 episodes of SAB occur annually in Australia (35/100,000 population). SAB is common, and a substantial proportion of cases may be preventable. The epidemiology is evolving, with >10% of community-onset SAB now caused by MRSA. This is an emerging infectious disease concern and is likely to impact on empiric antimicrobial drug prescribing in suspected cases of SAB.
• Subjects:
  Anti-Bacterial Agents Bacteremia Humans Incidence Methicillin Resistance Retrospective Studies Staphylococcal Infections Staphylococcus Aureus
• Source:
  Emerg Infect Dis. 11(4):554-561.
• Document Type:
  Journal Article
• Place as Subject:
  Australia
• Volume:
  11
• Issue:
  4
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:c7fb2149ffbd29bb5707f63cc77bff8422d3ef008ca80ef8ba260ca80c3d429f
• Download URL:
  https://stacks.cdc.gov/view/cdc/14710/cdc_14710_DS1.pdf
• File Type:
  [PDF - 201.25 KB ]